Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirbanibulin for Actinic Keratosis on Hands
NCT06026358Phase 4Withdrawn
- Sponsor
- Medical University of Graz
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tirbanibulin in actinic keratosis (AK), sponsored by Medical University of Graz. Planned start Oct 2023; status: withdrawn.
02
Drugs
tirbanibulin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT06026358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06026358.